Interleukin 17 production among patients with American cutaneous leishmaniasis. - Wikidata - wikimedia - TriplyDB

Interleukin 17 production among patients with American cutaneous leishmaniasis.

Interleukin 17 production among patients with American cutaneous leishmaniasis.

http://www.wikidata.org/entity/Q37319920

about

Immunoregulation in human American leishmaniasis: balancing pathology and protection IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection East Coast Fever Caused by Theileria parva Is Characterized by Macrophage Activation Associated with Vasculitis and Respiratory Failure.The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis Cutaneous Manifestations of Human and Murine Leishmaniasis Antigen-triggered interferon-γ and interleukin-10 pattern in cured mucosal leishmaniasis patients is shaped during the active phase of disease.The role of inflammatory, anti-inflammatory, and regulatory cytokines in patients infected with cutaneous leishmaniasis in Amazonas State, Brazil.Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL).Deception and manipulation: the arms of leishmania, a successful parasite Human macrophage response to L. (Viannia) panamensis: microarray evidence for an early inflammatory response IL-17 and Regulatory Cytokines (IL-10 and IL-27) in L. braziliensis Infection.Analysis of localized immune responses reveals presence of Th17 and Treg cells in cutaneous leishmaniasis due to Leishmania tropica.Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection The involvement of TLR2 and TLR4 in cytokine and nitric oxide production in visceral leishmaniasis patients before and after treatment with anti-leishmanial drugs.Murine model of chronic L. (Viannia) panamensis infection: role of IL-13 in disease.The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis.Protein biomarkers discriminate Leishmania major-infected and non-infected individuals in areas endemic for cutaneous leishmaniasis.Gene Expression Profile of High IFN-γ Producers Stimulated with Leishmania braziliensis Identifies Genes Associated with Cutaneous Leishmaniasis Atypical Manifestations of Cutaneous Leishmaniasis in a Region Endemic for Leishmania braziliensis: Clinical, Immunological and Parasitological Aspects.Neutrophils and macrophages work in concert as inducers and effectors of adaptive immunity against extracellular and intracellular microbial pathogens.Pro- and anti-inflammatory cytokines in children with malaria in Franceville, Gabon.Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.The Role of CD4 and CD8 T Cells in Human Cutaneous Leishmaniasis.CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly.Chemokines and chemokine receptors expression in the lesions of patients with American cutaneous leishmaniasis.American cutaneous leishmaniasis: In situ immune response of patients with recent and late lesions.Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.Leishmania braziliensis amastigotes stimulate production of IL-1β, IL-6, IL-10 and TGF-β by peripheral blood mononuclear cells from nonendemic area healthy residents.Th17 cells and neutrophils: Close collaborators in chronic Leishmania mexicana infections leading to disease severity.Effector memory CD4(+) T cells differentially express activation associated molecules depending on the duration of American cutaneous leishmaniasis lesions.A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates.Protective and pathologic immune responses in human tegumentary leishmaniasis.A live Leishmania major vaccine containing CpG motifs induces the de novo generation of Th17 cells in C57BL/6 mice.Quinolinic alkaloids from Galipea longiflora Krause suppress production of proinflammatory cytokines in vitro and control inflammation in vivo upon Leishmania infection in mice.Serotonin transporter protein overexpression and association to Th17 and T regulatory cells in lupoid leishmaniasis.Analysis of the expression of toll-like receptors 2 and 4 and cytokine production during experimental Leishmania chagasi infection.The Equivocal Role of Th17 Cells and Neutrophils on Immunopathogenesis of Leishmaniasis.Increased Th17 functions are accompanied by Tregs activities in lupoid leishmaniasis.Influence of the Notch system in the therapeutic response of American tegumentary leishmaniasis.Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells

P2860

Q26850280-FC542871-DB7B-4203-A35F-64FEFD26C70A Q27335548-B1D46835-D767-4E96-9D94-DCF805191BFF Q33432352-4A1E114B-95D5-42D1-A900-9B3555434E6F Q33719037-31BA484C-4346-4CFA-9000-91C20A35866F Q33839048-B949E27F-C5D8-456A-8341-C0A6FC682A6B Q34065388-156AFE2C-31EC-49AB-A79C-17DA94A0340D Q34257064-53A7022F-EC7F-4588-969E-01EE43D1365A Q34314518-56929354-E085-4794-92F1-5894122A3C34 Q34369161-43912853-C25E-4807-8064-F87D2D2E3A6E Q34474604-460E5F55-3C1E-4FB6-B651-F80D1B4E46CE Q34799364-8788A588-5B09-4DDF-943C-87D437A48153 Q35051071-C3697E41-8E89-48B4-919D-9A3D57DF4EDC Q35105666-521FF6A9-2C7B-435F-8C8F-0DD86B097009 Q35112512-3540C4FD-CB65-45BB-A4B7-324DB3234DE0 Q35786380-B70C4F9F-3895-4F7D-8E6E-6A1E4AE4318E Q35913098-88161C53-83D0-4221-8A2B-BACB41275A4A Q35968320-EDAFDC47-AFE7-44CC-8166-75B4FB83811F Q36199662-E271B00A-4150-49B2-82AF-EA6CF8C1D137 Q36209634-EC74B679-B46D-4374-B7AD-20B55004182B Q37683238-4DEA287D-C993-4C02-A66A-7EDEB8430DEE Q37692211-042FEED5-694A-478D-8D91-C72E46733F5D Q38051035-95464239-5900-4930-919C-2E82BDA4A7C2 Q38261036-956D5CFB-5054-4BCC-9AF2-13791D199E97 Q38387770-E4383FE1-269A-46FE-AA4A-7B7CB114058A Q38567412-8E700B02-F1F5-4954-93E7-7BE0E59596C6 Q38940537-D3F55665-005E-49CE-9932-03FFF744A890 Q38962452-341B9124-7FA9-4415-85F1-CD170C5BA99B Q39027155-01C61638-4EB3-4016-8C5A-1BBB39B42B73 Q40329762-E211C4A7-B92A-405A-B73A-0B8AE42F343F Q40722535-29283E34-C258-46B7-82E7-2A5230147E04 Q41186389-D7B1332D-36F9-4DC8-BD60-6861BA0EF0FB Q41971721-DEB2DCBF-CC7E-4519-AC46-0E20180D9CEC Q42670769-EFD5F23A-F3AF-4701-AAC2-F291F90D6A43 Q43754010-EC2DF745-2D53-4567-8F47-F6B67681BE8C Q44104220-EFE24643-3897-4569-9E88-1A4889AA286D Q44805980-1EC2FAE6-AEC4-4D21-97C9-FB8384988F29 Q46099419-3898E57D-D3B6-491F-A0BD-13B4FAC8CB68 Q46247986-41220E86-DDEF-40C4-BF79-62AEAED4DDB4 Q50644972-AC9B1921-0470-4829-8E97-DA8A0E92F4DB Q57275755-D133BB33-8D8E-442E-A438-96224E253F8D

P2860

Interleukin 17 production among patients with American cutaneous leishmaniasis.

http://www.wikidata.org/entity/Q37319920

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Interleukin 17 production among patients with American cutaneous leishmaniasis.

@en

Interleukin 17 production among patients with American cutaneous leishmaniasis.

@nl

type

label

Interleukin 17 production among patients with American cutaneous leishmaniasis.

@en

Interleukin 17 production among patients with American cutaneous leishmaniasis.

@nl

prefLabel

Interleukin 17 production among patients with American cutaneous leishmaniasis.

@en

Interleukin 17 production among patients with American cutaneous leishmaniasis.

@nl

P1433

Q37319920-72768622-7D1C-451B-AE3E-B60D0CDEBDA0

P1476

Q37319920-B857F905-73CE-461A-942F-D255FAA77D52

P2093

Q37319920-0575E8F5-6A74-4D05-B40C-371A4067E0AC

Q37319920-6DC3B981-1FD9-41A8-9F40-E97031582834

Q37319920-975299CE-798D-4C3C-A914-4FCA7F6E2369

Q37319920-B15DCC6F-BD7D-4946-827C-3093F274928F

Q37319920-CB92063C-EE8F-4677-ABED-1A465AB3E1E7

Q37319920-CCF359C3-5558-406D-9F5D-501344AB86A2

Q37319920-FF20B7EA-34F3-4282-B299-6160B64F69B0

P2860

Q37319920-082A6E68-2C9D-4582-B397-47E2982E7519

Q37319920-1B411778-EE16-4026-9968-7B14A0973AD3

Q37319920-35663CA8-EE2D-4E3D-B1E4-844384CF7E28

Q37319920-3F7A7C95-D21F-4DE5-BCA3-89B419962989

Q37319920-52C80268-B318-45DB-ADD2-B1066D841F5D

Q37319920-632DA9BA-81DB-41DD-84BE-178711B2D593

Q37319920-71981494-6699-4D0C-B0C8-18F32446058C

Q37319920-720B31F7-9D4D-400A-A808-E88577E6157F

Q37319920-8CFEB42B-975F-4EEF-96A3-3AF12D238183

Q37319920-B782E224-0E59-45A6-9ADC-AB29651B46DF

P304

Q37319920-41532CAF-5157-4D6A-AFC9-9FC21560C083

P31

Q37319920-C0990013-C21D-4AFA-B0E0-39730561EC35

P356

Q37319920-41524437-796E-43BA-88EE-362C315F082D

P407

Q37319920-B5187D3D-3C8E-41FE-9DD9-56F4B32BC11E

P433

Q37319920-736122A8-4F66-44EE-96A4-9FF2EB297F78

P478

Q37319920-C05BAD7C-6111-4AE7-B9AE-FF1B6A86EB30

P50

Q37319920-8DE7EC9E-E6A0-493D-84CC-041FE1C4A2B4

P577

Q37319920-28CECE29-5550-4EB4-A259-5568B56D3AA8

P5875

Q37319920-A8392C37-F758-4C42-B25A-BCB234389F01

P698

Q37319920-8865CBF8-6D30-4D10-A8B6-ADCBD2278278

P921

Q37319920-8cbfdcbc-4bec-4c8a-84d8-254767e0e601

Q37319920-FF03FA5F-EB23-4E42-AED2-619B510E9AAE

P932

Q37319920-32ADAA63-44F3-47C1-ADCE-EF074442DB7C

P356

P1433

The Journal of Infectious Diseases

P1476

Interleukin 17 production among patients with American cutaneous leishmaniasis.

@en

P2093

Daniela Faria

http://www.w3.org/2001/XMLSchema#string

Edgar M Carvalho

http://www.w3.org/2001/XMLSchema#string

Márcia Nascimento

http://www.w3.org/2001/XMLSchema#string

Olívia Bacellar

http://www.w3.org/2001/XMLSchema#string

Phillip Scott

http://www.w3.org/2001/XMLSchema#string

Thiago M Cardoso

http://www.w3.org/2001/XMLSchema#string

Walderez O Dutra

http://www.w3.org/2001/XMLSchema#string

P2860

Leishmania braziliensis infection induces dendritic cell activation, ISG15 transcription, and the generation of protective immune responses

Interleukin-17 family and IL-17 receptors

Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17

Interleukin-17 family members and inflammation

Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection.

Up-regulation of Th1-type responses in mucosal leishmaniasis patients

Interleukin-17 as an effector molecule of innate and acquired immunity against infections.

Induction and effector functions of T(H)17 cells.

Pentoxifylline down modulate in vitro T cell responses and attenuate pathology in Leishmania and HTLV-I infections.

Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis

P304

75-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/599380

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

200

http://www.w3.org/2001/XMLSchema#string

P50

Kenneth J. Gollob

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26247730

http://www.w3.org/2001/XMLSchema#string

P698

19476435

http://www.w3.org/2001/XMLSchema#string

P921

P932

2732405

http://www.w3.org/2001/XMLSchema#string